retatrutide ly3437943 phase 2 trial obesity nejm 2023 Back in we saw truly unprecedented data for a new drug called ' Retatrutide', which binds to — and activates — 3 receptors: the GLP1 receptor (like Semaglutide), the GIP receptor (like Retatrutide vs Tirzepatide for Obesity
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13









:max_bytes(150000):strip_icc()/VWH-GettyImages-1469751146-5eff6dd0b38449ff9dca9313c7c393d5.jpg)














